- Home
- HCKT vs BVS Comparison
HCKT vs BVS Comparison
Compare HCKT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCKT
- BVS
- Stock Information
- Founded
- HCKT 1991
- BVS 2011
- Country
- HCKT United States
- BVS United States
- Employees
- HCKT N/A
- BVS N/A
- Industry
- HCKT Professional Services
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HCKT Consumer Discretionary
- BVS Health Care
- Exchange
- HCKT Nasdaq
- BVS Nasdaq
- Market Cap
- HCKT 843.0M
- BVS 883.7M
- IPO Year
- HCKT 1998
- BVS 2021
- Fundamental
- Price
- HCKT $32.12
- BVS $11.24
- Analyst Decision
- HCKT Strong Buy
- BVS Strong Buy
- Analyst Count
- HCKT 3
- BVS 3
- Target Price
- HCKT $30.00
- BVS $15.00
- AVG Volume (30 Days)
- HCKT 84.8K
- BVS 297.3K
- Earning Date
- HCKT 11-04-2024
- BVS 11-05-2024
- Dividend Yield
- HCKT 1.02%
- BVS N/A
- EPS Growth
- HCKT N/A
- BVS N/A
- EPS
- HCKT 1.22
- BVS N/A
- Revenue
- HCKT $300,739,000.00
- BVS $555,061,000.00
- Revenue This Year
- HCKT $8.66
- BVS $11.24
- Revenue Next Year
- HCKT $5.16
- BVS $6.77
- P/E Ratio
- HCKT $26.31
- BVS N/A
- Revenue Growth
- HCKT 4.09
- BVS 10.40
- 52 Week Low
- HCKT $20.23
- BVS $3.90
- 52 Week High
- HCKT $32.83
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- HCKT 68.09
- BVS 43.94
- Support Level
- HCKT $31.58
- BVS $10.95
- Resistance Level
- HCKT $32.39
- BVS $11.54
- Average True Range (ATR)
- HCKT 0.54
- BVS 0.48
- MACD
- HCKT -0.16
- BVS -0.04
- Stochastic Oscillator
- HCKT 59.28
- BVS 13.84
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP-based executive advisory, strategic consulting, and digital transformation firm. It provides Generative Artificial Intelligence ("Gen AI") strategy, operations, finance, human capital management, strategic sourcing, procurement, and information technology. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.